Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction

The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators

Research output: Contribution to journal › Article › peer-review

803 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction'. Together they form a unique fingerprint.

Medicine & Life Sciences